Bookmark and Share

Compound Summary for: CID 208924


Also known as: AG-E-94059; AC1L4LMA; UNII-EUT3557RT5; EUT3557RT5; CTK4G2535; 289893-25-0; DB05025
Molecular Formula: C14H20ClN3O3   Molecular Weight: 313.7799   InChIKey: SGEIEGAXKLMUIZ-CYBMUJFWSA-N
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Biomolecular Interactions and Pathways
Chemical and Physical Properties
_ _